Vilco Pharma Private Limited
About Vilco Pharma Private Limited
Data last updated:
Vilco Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate financing segment of the financial services sector. It was incorporated on 26 December 1973 and has been in existence for over 53 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1973PTC017094. Its GSTIN is 27AAACV4176B1ZI (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹3.06 Lakh. It is led by directors Milan Rasiklal Mehta and Pritul Gajendra Sanghavi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Haria Center 8 Subhash Road Vile Parle East, Mumbai, Maharashtra, India – 400057.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.27 Cr, a growth of 64% compared to the previous year. For the same year it recorded a net profit of ₹34.54 Lakh (net margin 10.6%) and EBITDA of ₹1.63 Cr (EBITDA margin 49.9%). Revenue has grown at a compounded annual rate (CAGR) of 85% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹9.31 Cr and satisfied charges of ₹46.7 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHaria Center 8 Subhash Road Vile Parle East, Mumbai, Maharashtra, India – 400057
- IndustryFinancial Services, Real Estate Financing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vilco Pharma Private Limited
The main business activity of Vilco Pharma is real estate. In detail, this covers real estate activities with own or leased property.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vilco Pharma Private Limited FY 2024 filings available
Vilco Pharma Private Limited reported revenue of ₹3.27 Cr (up 64% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Vilco Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 64% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vilco Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.63 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹34.54 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vilco Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 49.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vilco Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vilco Pharma Private Limited
Vilco Pharma Private Limited is compared with the companies closest to it by revenue in the BFSI industry (Real Estate Leasing). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tristar Accommodations Private Limited | ₹3.28 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Coimbatore, Tamil Nadu, India |
| Bhushan Foods Pvt.Ltd. | ₹3.28 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Delhi, India |
| Karthikeya Global India Private Limited | ₹3.28 Cr (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Real Feed Private Limited | ₹3.27 Cr (FY 2019) | •••• | •••• | 142.0% | •••• | Kolkata, West Bengal, India |
| Jeram Auto Malls & Realty Private Limited | ₹3.27 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Rajkot, Gujarat, India |
| Vilco Pharma Private Limited this company | ₹3.27 Cr (FY 2025) | •••• | •••• | 64.0% | •••• | Mumbai, Maharashtra, India |
| Citrine Properties Private Limited | ₹3.27 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Truworx Spaces Private Limited | ₹3.27 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Gurugram, Haryana, India |
| Tristar Ventures Private Limited | ₹3.26 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | New Delhi, Delhi, India |
| Prem Sagar Real Estates Private Limited | ₹3.26 Cr (FY 2020) | •••• | •••• | 123971.0% | •••• | Jaipur, Rajasthan, India |
| Brahaspati Real Estates Private Limited | ₹3.26 Cr (FY 2017) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Vilco Pharma by revenue in the BFSI industry (Real Estate Leasing), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Vilco Pharma Private Limited
Vilco Pharma Private Limited is audited by K.S. SUBRAHMANYAM AND CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K.S. SUBRAHMANYAM AND CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vilco Pharma Private Limited
Vilco Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pritul Gajendra Sanghavi | Additional Director | 10 Mar 2021 | 5 Years 7 Months | Current |
| Milan Rasiklal Mehta Also directs: Anakin Asset Holding LLP | Director | 01 Nov 2016 | 9 Years 11 Months | Current |
Ownership and Shareholding of Vilco Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vilco Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jul 2024 | Axis Bank Limited | ₹4 Cr | Open |
| 11 Jan 2021 | Axis Bank Limited | ₹4.99 Cr | Open |
| 24 Jan 2001 | The North Kanara Gsb Co-Op Bank Ltd. | ₹19.8 Lakh | Open |
| 22 Sep 1978 | State Bank of India | ₹5.73 Lakh | Open |
| 22 Sep 1978 | State Bank of India | ₹5.73 Lakh | Open |
Total charge records: 12 View all charges
Legal Cases of Vilco Pharma Private Limited
Vilco Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked between 01 Oct 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by C.I.T. of Income Tax-8, Bombay | Disposed |
| Bombay High Court | Court case (NMA) | Filed against the company by Commissioner of Income Tax-8 , Mumbai | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Vilco Pharma Private Limited
Employment history and EPFO contributions of people linked to Vilco Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vilco Pharma Private Limited
Vilco Pharma Private Limited has 7 board changes on record since 2009: 2 appointments and 5 cessations. The latest: Jaysukh Narshi Maru ceased to be Director on 10 Mar 2021.
19 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vilco Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vilco Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vilco Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vilco Pharma Private Limited
Vilco Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACV4176B1ZI | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vilco Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vilco Pharma Private Limited
Vilco Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate financing, within the financial services industry. It was incorporated on 26 December 1973 (53+ years old) and is registered under CIN U24239MH1973PTC017094.
Vilco Pharma reported revenue of ₹3.27 Cr for FY 2025 (up 64% YoY).
Vilco Pharma has 2 current directors:
- Pritul Gajendra Sanghavi - Additional Director
- Milan Rasiklal Mehta - Director
Vilco Pharma reported a net profit of ₹34.54 Lakh (net margin 10.6%) and EBITDA of ₹1.63 Cr (EBITDA margin 49.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vilco Pharma is 85% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 64%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vilco Pharma is 27AAACV4176B1ZI, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vilco Pharma is U24239MH1973PTC017094. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vilco Pharma has 2 court cases on record: 2 filed against it.
Vilco Pharma was incorporated on 26 December 1973, making it 53+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vilco Pharma by revenue are Tristar Accommodations Private Limited, Bhushan Foods Pvt.Ltd, Karthikeya Global India Private Limited, Real Feed Private Limited, Jeram Auto Malls & Realty Private Limited and 5 more, all in the BFSI industry (Real Estate Leasing).
Jaysukh Narshi Maru ceased to be Director on 10 Mar 2021. Pritul Gajendra Sanghavi was appointed as Additional Director on 10 Mar 2021. Bimal Kantilal Haria ceased to be Director on 01 Nov 2016. Vilco Pharma has 7 board changes on record in total.